Patients carrying the A(−816)C SNP showed enhanced anti-hypertension response to the angiotensin-converting enzyme (ACE) inhibitor imidapril, which is converted to its active metabolite, imidaprilat, by CES1 (Geshi et al., 2005). The gene discussed is ACE; the disease is hypertensive disorder.